These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15635489)

  • 1. Cancer, type 2 diabetes, and ageing: news from flies and worms.
    Hafen E
    Swiss Med Wkly; 2004 Dec; 134(49-50):711-9. PubMed ID: 15635489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional feedback in the insulin signalling pathway modulates ageing in both Caenorhabditis elegans and Drosophila melanogaster.
    Ivanov DK; Papatheodorou I; Ziehm M; Thornton JM
    Mol Biosyst; 2013 Jul; 9(7):1756-64. PubMed ID: 23624434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex.
    Jin F; Jiang K; Ji S; Wang L; Ni Z; Huang F; Li C; Chen R; Zhang H; Hu Z; Zha X
    Hum Mol Genet; 2017 Jan; 26(2):407-419. PubMed ID: 28013293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies.
    Venz R; Pekec T; Katic I; Ciosk R; Ewald CY
    Elife; 2021 Sep; 10():. PubMed ID: 34505574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.
    Gao X; Zhang Y; Arrazola P; Hino O; Kobayashi T; Yeung RS; Ru B; Pan D
    Nat Cell Biol; 2002 Sep; 4(9):699-704. PubMed ID: 12172555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans.
    Pinkston-Gosse J; Kenyon C
    Nat Genet; 2007 Nov; 39(11):1403-9. PubMed ID: 17934462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untangling Longevity, Dauer, and Healthspan in Caenorhabditis elegans Insulin/IGF-1-Signalling.
    Ewald CY; Castillo-Quan JI; Blackwell TK
    Gerontology; 2018; 64(1):96-104. PubMed ID: 28934747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours.
    Knowles MA; Hornigold N; Pitt E
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):597-602. PubMed ID: 12773163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of ageing: public or private?
    Partridge L; Gems D
    Nat Rev Genet; 2002 Mar; 3(3):165-75. PubMed ID: 11972154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tuberous sclerosis complex genes in tumor development.
    Mak BC; Yeung RS
    Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
    Nobukini T; Thomas G
    Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.
    Inoki K; Guan KL
    Hum Mol Genet; 2009 Apr; 18(R1):R94-100. PubMed ID: 19297407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOR and ageing: a complex pathway for a complex process.
    McCormick MA; Tsai SY; Kennedy BK
    Philos Trans R Soc Lond B Biol Sci; 2011 Jan; 366(1561):17-27. PubMed ID: 21115526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans.
    Lucanic M; Held JM; Vantipalli MC; Klang IM; Graham JB; Gibson BW; Lithgow GJ; Gill MS
    Nature; 2011 May; 473(7346):226-9. PubMed ID: 21562563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.
    Mrozek EM; Bajaj V; Guo Y; Malinowska IA; Zhang J; Kwiatkowski DJ
    PLoS One; 2021; 16(4):e0248380. PubMed ID: 33891611
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang S; Li F; Zhou T; Wang G; Li Z
    Front Endocrinol (Lausanne); 2020; 11():554994. PubMed ID: 33123086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic basis of tuberous sclerosis.
    Young J; Povey S
    Mol Med Today; 1998 Jul; 4(7):313-9. PubMed ID: 9743993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peroxiredoxin, PRDX-2, is required for insulin secretion and insulin/IIS-dependent regulation of stress resistance and longevity.
    Oláhová M; Veal EA
    Aging Cell; 2015 Aug; 14(4):558-68. PubMed ID: 25808059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.